Parameters | Before treatment | After treatment | P |
FSH, IU/mL | 4.82 ± 1.34 | 5.04 ± 1.35 | 0.220 |
LH, IU/mL | 5.05 ± 1.55 | 4.67 ± 1.16 | 0.211 |
LH/FSH | 1.17 ± 0.52 | 1.09 ± 0.67 | 0.062 |
Immune-reactive Insulin, mIU/L | 11.96 ± 4.92 | 10.07 ± 4.90 | 0.054 |
Leptin, ng/ml | 56.32 ± 14.84 | 32.84 ± 15.11 | <0.001 |
Е1, pmol/l | 716.13 ± 457.88 | 575.54 ± 383.90 | 0.049 |
Е2, pmol/l | 97.00 ± 43.08 | 80.44 ± 25.86 | 0.032 |
Testosterone, nmol/l | 1.73 ± 0.80 | 1.75 ± 0.77 | 0.860 |
Progesterone, nmol/l | 18.97 ± 13.52 | 25.33 ± 11.99 | 0.030 |
Fasting blood sugar (FBS), mmol/l | 4.82 ± 0.64 | 4.25 ± 0.53 | <0.001 |
2 hours FBS, mmol/l | 5.04 ± 0.94 | 4.86 ± 0.65 | 0.289 |
HOMA-IR | 2.61 ± 1.06 | 1.92 ± 0.95 | 0.002 |
Cholesterol, mmol/l | 5.39 ± 0.80 | 4.81 ± 0.83 | <0.001 |
Triglycerides, mmol/l | 1.56 ± 0.62 | 1.19 ± 0.53 | 0.004 |
HDL, mmol/l | 1.31 ± 0.48 | 1.52 ± 0.51 | 0.092 |
LDL, mmol/l | 3.41 ± 0.66 | 2.61 ± 0.82 | 0.001 |
Atherogenic Index plasma (AIP) | 3.74 ± 1.67 | 2.39 ± 0.91 | <0.001 |